ARISTADA (Alkermes, Inc.)


Welcome to the PulseAid listing for the ARISTADA drug offered from Alkermes, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Alkermes, Inc.
NON-PROPRIETARY NAME: aripiprazole lauroxil
SUBSTANCE NAME: ARIPIPRAZOLE LAUROXIL
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAMUSCULAR
DOSAGE FORM: INJECTION, SUSPENSION, EXTENDED RELEASE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2015-10-05
END MARKETING DATE: 0000-00-00


ARISTADA HUMAN PRESCRIPTION DRUG Details:

Item DescriptionARISTADA from Alkermes, Inc.
LABELER NAME: Alkermes, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 441(mg/1.6mL)
START MARKETING DATE: 2015-10-05
END MARKETING DATE: 0000-00-00
PRODUCT ID: 65757-401_6346fbb7-8257-4b61-9301-3eb408a17646
PRODUCT NDC: 65757-401
APPLICATION NUMBER: NDA207533

Other ARIPIPRAZOLE LAUROXIL Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Alkermes, Inc.ARISTADA